The solvent stability of bromovirus allows for delivery of hydrophobic chemotherapeutic drugs
Open Access
- 22 September 2025
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Materials Advances
- Vol. 7 (1) , 469-483
Abstract
The solvent stability of bromoviruses (BMV/CCMV) enables their use as nanocarriers, improving the delivery and efficacy of hydrophobic drugs to breast cancer cells.Keywords
This publication has 54 references indexed in Scilit:
- Sensitivity Evaluation of Enveloped and Non-enveloped Viruses to Ethanol Using Machine Learning: A Systematic ReviewFood and Environmental Virology, 2023
- Camptothecin-Carrying Cobalt-Doped Copper Sulfide NanoparticlesJournal of Cluster Science, 2023
- Targeted Enzymatic VLP‐Nanoreactors with β‐Glucocerebrosidase Activity as Potential Enzyme Replacement Therapy for Gaucher's DiseaseChemMedChem, 2022
- Virus‐Based Nanoreactors with GALT Activity for Classic Galactosemia TherapyChemMedChem, 2021
- Doxorubicin‐Loaded Physalis Mottle Virus Particles Function as a pH‐Responsive Prodrug Enabling Cancer TherapyBiotechnology Journal, 2020
- Development of target‐tunable P22 VLP‐based delivery nanoplatforms using bacterial superglueBiotechnology and Bioengineering, 2019
- Breast Cancer TreatmentJAMA, 2019
- Synthesis of Biomolecule‐Modified Mesoporous Silica Nanoparticles for Targeted Hydrophobic Drug Delivery to Cancer CellsSmall, 2011
- Genome‐Free Viral Capsids as Multivalent Carriers for Taxol DeliveryAngewandte Chemie International Edition, 2009
- Comparison of the Native CCMV Virion within VitroAssembled CCMV Virions by Cryoelectron Microscopy and Image ReconstructionVirology, 1998